Safety, Tolerability, and Pharmacokinetics of a Single Dose of NBI-98854 in Subjects With Mild,Moderate, or Severe Hepatic Insufficiency

Clinical trial NCT01916993 · COMPLETED

Trial details

NCT number: NCT01916993
Sponsor: Neurocrine Biosciences
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Safety, Tolerability, and PK of NBI-98854 in Hepatically Impaired Subjects

Start date: 2013-08-01
Primary completion: 2013-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.